Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jinyue Lu

Showing results (11-20 of 19) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 19 results.
Open Life Sciences|December 1, 2025
Lipoxin A4 improves myocardial ischemia/reperfusion injury through the Notch1-Nrf2 signaling pathwayXueyun Yan, Anbang Chen, Yuanqi Gong, et al.
International Immunopharmacology|October 16, 2025
CD36-mediated fatty acid metabolic reprogramming activates synovial fibroblasts and promotes rheumatoid arthritis progressionJiayao Hao, Jianxiong Zheng, Chunhua Liu, et al.
Chemical Communications (Cambridge, England)|April 9, 2020
Boron-doped carbon nanodots dispersed on graphitic carbon as high-performance catalysts for acetylene hydrochlorinationYuxue Yue, Bolin Wang, Saisai Wang, et al.
Acta Pharmaceutica Sinica. B|May 4, 2023
Berberine ameliorates chronic kidney disease through inhibiting the production of gut-derived uremic toxins in the gut microbiotaLibin Pan, Hang Yu, Jie Fu, et al.
Journal of Pharmaceutical Analysis|October 16, 2023
Gut microbiota-based pharmacokinetic-pharmacodynamic study and molecular mechanism of specnuezhenide in the treatment of colorectal cancer targeting carboxylesteraseHang Yu, Hui Xu, Xinyu Yang, et al.
Frontiers in Cellular and Infection Microbiology|June 1, 2023
Revitalizing myocarditis treatment through gut microbiota modulation: unveiling a promising therapeutic avenueJingyue Wang, Xianfeng Zhang, Xinyu Yang, et al.
Journal of Pharmaceutical and Biomedical Analysis|August 6, 2024
Corrigendum to "Dissecting the antitumor effects of Scutellaria barbata: Initial insights into the metabolism of scutellarin and luteolin by gut microbiota" [J. Pharm. Biomed. Anal. 248 (2024) 116325]Xianfeng Zhang, Jingyue Wang, Jie Fu, et al.
Journal of Pharmaceutical and Biomedical Analysis|July 3, 2024
Dissecting the antitumor effects of Scutellaria barbata: Initial insights into the metabolism of scutellarin and luteolin by gut microbiotaXianfeng Zhang, Jingyue Wang, Jie Fu, et al.
Acta Pharmaceutica Sinica. B|October 24, 2025
<i>Bacteroi</i> <i>des fragilis</i>-derived succinic acid promotes the degradation of uric acid by inhibiting hepatic AMPD2: Insight into how plant-based berberine ameliorates hyperuricemiaLibin Pan, Ru Feng, Jiachun Hu, et al.
Pageof 2

Showing results (11-20 of 19) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 19 results.
Open Life Sciences|December 1, 2025
Lipoxin A4 improves myocardial ischemia/reperfusion injury through the Notch1-Nrf2 signaling pathwayXueyun Yan, Anbang Chen, Yuanqi Gong, et al.
International Immunopharmacology|October 16, 2025
CD36-mediated fatty acid metabolic reprogramming activates synovial fibroblasts and promotes rheumatoid arthritis progressionJiayao Hao, Jianxiong Zheng, Chunhua Liu, et al.
Chemical Communications (Cambridge, England)|April 9, 2020
Boron-doped carbon nanodots dispersed on graphitic carbon as high-performance catalysts for acetylene hydrochlorinationYuxue Yue, Bolin Wang, Saisai Wang, et al.
Acta Pharmaceutica Sinica. B|May 4, 2023
Berberine ameliorates chronic kidney disease through inhibiting the production of gut-derived uremic toxins in the gut microbiotaLibin Pan, Hang Yu, Jie Fu, et al.
Journal of Pharmaceutical Analysis|October 16, 2023
Gut microbiota-based pharmacokinetic-pharmacodynamic study and molecular mechanism of specnuezhenide in the treatment of colorectal cancer targeting carboxylesteraseHang Yu, Hui Xu, Xinyu Yang, et al.
Frontiers in Cellular and Infection Microbiology|June 1, 2023
Revitalizing myocarditis treatment through gut microbiota modulation: unveiling a promising therapeutic avenueJingyue Wang, Xianfeng Zhang, Xinyu Yang, et al.
Journal of Pharmaceutical and Biomedical Analysis|August 6, 2024
Corrigendum to "Dissecting the antitumor effects of Scutellaria barbata: Initial insights into the metabolism of scutellarin and luteolin by gut microbiota" [J. Pharm. Biomed. Anal. 248 (2024) 116325]Xianfeng Zhang, Jingyue Wang, Jie Fu, et al.
Journal of Pharmaceutical and Biomedical Analysis|July 3, 2024
Dissecting the antitumor effects of Scutellaria barbata: Initial insights into the metabolism of scutellarin and luteolin by gut microbiotaXianfeng Zhang, Jingyue Wang, Jie Fu, et al.
Acta Pharmaceutica Sinica. B|October 24, 2025
<i>Bacteroi</i> <i>des fragilis</i>-derived succinic acid promotes the degradation of uric acid by inhibiting hepatic AMPD2: Insight into how plant-based berberine ameliorates hyperuricemiaLibin Pan, Ru Feng, Jiachun Hu, et al.
Pageof 2